Versant Ventures

Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firms emphasis is on biotechnology companies that are discovering and developing novel therapeutics. With $2.4 billion under management and offices in the U.S., Canada and Europe, Versant has built a team with deep investment, operating and clinical expertise that enables a hands-on approach to company building. Since the firms founding in 1999, more than 70 Versant companies have achieved successful acquisitions or IPOs. For more information, please visit www.versantventures.com

Biopharmaceuticals,medical devices,life science opportunities,venture capital,and company creation

Versant ventures operates in the Venture capital and private equity principals industry.

Versant ventures's revenue is 11m - 100m

Versant ventures has 51 - 200 employees.